Skip to main content

Table 1 Characteristics of individual recipients and their perioperative period

From: Single mutidrug resistant enterobacteriacae donor-derived infection in four solid organ transplant recipients: a case report

number of patient age/sex/BMI age/sex/BMI transplanted organ principal disease prior to SOT hospitalization/ATB therapy immunological risk immunosuppression antibiotic prophylaxis complication therapy antibiotic therapy LOS [days] outcome
1 60/male/26.6 kidney chronic kidney disease, diabetic nephropathy, kidney transplantation 4 years ago, early graftectomia due to renal vein thrombosis, cardiac anamnesis: tricuspid valve repair due to regurgitation, atrial fibrillation (warfarine), EF LV 50%), habitual hypotension (midodrine), hemodialysis (AV shunt) no/no high 2nd kidney transplantation, PRA act 0%, max 14% thymoglobuline and methylprednisolone (induction), thymoglobuline, tacrolimus, mycophenolate mofetil, prednisone, withdrawal on the 3rd day cefuroxime (2 days) early hemodynamic instability, left heart insuficiency, arythmia, sepsis, visceral ischemia surgery, inotropes, antiarythmics, therapy of the septic shock acording to guidleines, CVVHD, mechanical ventilation for 48 h since 2nd postoperative day meropenem 2 g á 8 h, amikacin 2 g á 24 h 3 death on the 2nd day after SOT, sepsis, multiorgan failure
2 32/male/25.1 kidney chronic kidney disease, chronic glomerulonephritis, previous 2 kidney transplantations, peritoneal dialysis, 2 episodes of peritonitis no/no high high level of DSA, PRA act 36%, max 79% plasmapheresis before the transplantation thymoglobuline (3 doses), intravenous immunoglobuline (3 doses), tacrolimus, mycophenolate mofetil, prednisone cefuroxime (2 days) haemorrhage, strangulated sigma loop around CAPD catether, haemorrhagic shock surgery, therapy of circulatory shock, CVVHD, mechanical ventilation for 52 h since 2nd postoperative day meropenem 2 g á 8 h, metronidazole 500 mg á 8 h 4 death on the 3th day after SOT, sepsis, multiorgan failure
3 49/male/23.1 liver HCV related liver cirrhosis Child-Pugh C, portal hypertension, hepatorenal syndrome, ascites, encephalopathy yes/yes low, PRA 0% methylprednisolone (induction), tacrolimus, mycophenolate mofetil, prednisone piperacilin/tazobactam (3 days) none usual postoperative care, early extubation since 3rd postoperative day meropenem 1 g á 8 h (for 10 days) 22 alive (2018) with good graft function
4 59/female/25.8 pancreas islets labile diabetes mellitus type I, daily episodes of hypoglycemia, chronic kidney disease, cholestasis of the liver no/no low, PRA act 0%, max 13% thymoglobuline and methylprednisolone (induction), tacrolimus, rapamycine – with drawal on the 2nd day piperacilin/tazobactam (3 days) haemorrhage, pneumonia, haemorrhagic and septic shock, acute kidney injury and multiorgan failure several surgeries, therapy of circulatory shock, CVVHD, intermitent dialysis, mechanical ventilation for 540 h, tracheostomy piperacilin/tazobactam 2,25 g á 6 h, on the 4th postoperative day changed to meropenem 1 g á 6 h, amikacin acording to serum level (for 10 days) 81 alive (2018), early failure of the transplanted islets, 2nd successfull islets transplantation in 2018
5 40/male/28.4 heart dilatation cardiomyopathy, EF LV < 20%, pulmonary hypertension, ICD, chronic kidney disease yes/yes low, PRA 0% thymoglobuline, methylprednisolone, and mycophenolate mofetil (induction), thymoglobuline, tacrolimus, methylpredisolone, mycophenolate mofetil cefriaxone (3 days) none usual postoperative care, mechanical ventilation for 13 h since 2nd postoperative day meropenem 1 g á 6 h (for 10 days) 40 alive (2018), good graft function